Facebook
Twitter
LinkedIn
Forward
Updates on the Management of Asthma
Overview
Purpose
Mary Greeley Medical Center Grand Rounds is a multidisciplinary clinical activity that maintains, develops, or increases a physician's knowledge, skills, professional performance, and relationships to provide services for patients, the public, or the profession.
Target Audience
Physicians, advanced practice providers, nurses, medical students (rotating), non-medical students (rotating), and healthcare administrators.
Learning Objectives
- Describe asthma endotypes and how their associated immune pathways contribute to airway inflammation and asthma.
- Define and differentiate AIR and SMART therapy.
- Explain how updated GINA guidelines have changed our approach to asthma reliever therapy.
- Identify the available biologics for asthma.
- Discuss how understanding asthma endotypes enables personalized treatment strategies.
Speaker
Jason Cascio, MD, PhD
Allergist-Immunologist, McFarland Clinic
Dr. Cascio received his Bachelor of Science in Biology from Knox College in Galesburg, Illinois. He received his Doctor of Philosophy in Immunology from the University of Missouri in Columbia, Missouri, and his Medical Doctorate from Loyola University Chicago in Maywood, Illinois. Dr. Cascio completed his Internal Medicine Residency and Allergy/Immunology Fellowship from the University of Iowa in Iowa City, Iowa.
As an Allergist-Immunologist, Dr. Cascio provides services to adults and children, including assessment of allergy symptoms, testing, and treatment, including allergy shots. He diagnoses and treats allergic diseases such as asthma, rhinitis, hay fever, anaphylaxis, angioedema, hives, and eczema. He also diagnoses and treats allergic reactions to foods, drugs, and insect stings. Dr. Cascio specializes in evaluating and managing immune deficiency diseases and other immune-based disorders.
Location
CE Credits
Accreditation Statements
- DO: Des Moines University Medicine and Health Sciences (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 1.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
EDUCATIONAL GRANTS
No ineligible company provided financial support for this continuing education activity.
DISCLOSURES
The speaker(s) will disclose if any pharmaceuticals, medical procedures, or devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The activity director is responsible for determining educational content and selecting speakers.
Relevant to the content of this educational activity, the following individual(s) have conflict(s) with ineligible companies to disclose. All relevant financial relationships have been mitigated.
- Jason Cascio, MD, PhD - Speaker
- Principal Investigator: Nocion Therapeutics, Inc. and AstraZeneca
- Sub-investigator: Bellus Health, Inc.
CME Committee
- No Mary Greeley Medical Center CME Committee member who planned this activity has any financial relationship to disclose relating to the content.
Gifts to the Mary Greeley Medical Center Foundation from Mary Greeley Medical Center, McFarland Clinic, and Availa Bank support this program. The content and selection of speaker(s) are the responsibility of the Mary Greeley Medical Center for Continuing Medical Education Committee, not the sponsors of this program.
DISCLAIMER
The information provided in this activity is for continuing education purposes only. It is not a substitute for a healthcare provider's independent medical judgment regarding diagnostic and treatment options for a specific patient's medical condition.
Available Credit
- 1.00 AOA Category 2A